And, fluoxetine treatment reversed the increase of serum RvD1 in adolescent patients with MDD, significantly decreased the levels of pro-inflammatory cytokine IL-1β and NLRP3, while significantly increased the levels of anti-inflammatory cytokine IL-4 compared to baseline. This evidence concerns the gene IL1B and major depressive disorder.